NCT07011082

Brief Summary

Young children aged 0-4 years may be exposed to adverse childhood experiences (ACEs) and/or early life adversity (ELA), which are linked with worse physical and mental health across their lifespan. On the other hand, positive childhood experiences (PCEs) can build resilience and prevent or protect against these detrimental outcomes. Data analyses will assess the interactions of ACEs, PCEs, parenting, and poverty on the early social psychology of childhood and develop objective measures for altered stress regulation using hair cortisol as a chronic stress biomarker.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
600

participants targeted

Target at P75+ for all trials

Timeline
43mo left

Started Nov 2024

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress29%
Nov 2024Dec 2029

Study Start

First participant enrolled

November 18, 2024

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

May 30, 2025

Completed
9 days until next milestone

First Posted

Study publicly available on registry

June 8, 2025

Completed
4.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2029

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2029

Last Updated

June 24, 2025

Status Verified

May 1, 2025

Enrollment Period

5 years

First QC Date

May 30, 2025

Last Update Submit

June 18, 2025

Conditions

Keywords

Toxic stressInfantsCortisolOxytocinEarly child development

Outcome Measures

Primary Outcomes (3)

  • Identification of Participants hair cortisol concentrations (HCC) and hair oxytocin concentrations (HOC)

    Hair samples measured at study entry and 6 month intervals up to 2 years (Study entry, 6-month, 12-month, 18-month, 24-month)

  • Hair Cortisol Concentration (HCC), nanograms cortisol/milligram of hair

    From enrollment to end of study in 2 years

  • Hair Oxytocin Concentration (HOC), picogram oxytocin/milligram of hair

    From enrollment to end of study in 2 years

Study Arms (2)

Healthy Infants

Ages between 6-24 months

Other: Stress preventative measures

Healthy Mothers

Mothers with children aged between 6-24 months who are eligible for the HBS-II

Other: Stress preventative measures

Interventions

These studies will address fundamental gaps in our current knowledge and establish a scientific framework to investigate the long-term effects of early childhood adversity, physical or emotional trauma, child maltreatment, or other adverse experiences in early childhood, as well as the preventive and protective effects of loving, nurturing, and consistent caregiving offered to young children during their early childhood

Healthy InfantsHealthy Mothers

Eligibility Criteria

Age6 Months - 24 Months
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)
Sampling MethodProbability Sample
Study Population

Normal, healthy children aged 6 months to 24 months and their biological mothers (or father, if mother is not able to participate), in order to study the impact of early social ecology on their nascent social psychology, growth, and development in early childhood.

You may qualify if:

  • Normal, healthy children aged 6 months to 24 months and their mothers (or father, if mother is not able to participate).
  • Living in Santa Clara County, San Mateo County, or Alameda County in Northern California.
  • Willing to give their home address (in order to receive the study kits at home).
  • Committed to regular follow-up at 6-month intervals for the full study duration of 2 years.

You may not qualify if:

  • Children with tinea capitis, alopecia areata, scalp eczema, dermatitis, or other scalp conditions.
  • Children exposed to systemic steroid therapy for any diagnosis in the 3 months prior to study entry.
  • Children receiving any other prescription drugs that alter HPA axis function or cortisol release, if the period of exposure is 2 weeks or longer within the 3 months prior to study entry.
  • Children with chronic medical conditions such as cystic fibrosis, sickle cell disease, asthma, eczema, or other chronic conditions.
  • Children with known developmental delay, Trisomy-21 and other chromosomal anomalies, seizure disorders, chronic pain, cerebral palsy, or other disabilities.
  • Children whose hair has received chemical exposures (e.g., dying, bleaching, chemical straightening, perming) in the 90 days prior to study entry or for 90 days before each follow-up appointment during the 2-year study period.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Stanford University

Palo Alto, California, 94304, United States

RECRUITING

Central Study Contacts

Kanwaljeet J.S. Anand, MBBS, DPhil

CONTACT

Cynthia R Rovnaghi, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director of Stanford Child Wellness Lab

Study Record Dates

First Submitted

May 30, 2025

First Posted

June 8, 2025

Study Start

November 18, 2024

Primary Completion (Estimated)

December 1, 2029

Study Completion (Estimated)

December 1, 2029

Last Updated

June 24, 2025

Record last verified: 2025-05

Data Sharing

IPD Sharing
Will not share

IPD will not be shared because of proprietary methods used for analysis of hair samples.

Locations